You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

List of Excipients in API clopidogrel


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing clopidogrel

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Sanofi-Aventis US LLC PLAVIX clopidogrel 0024-1171 CARNAUBA WAX
Sanofi-Aventis US LLC PLAVIX clopidogrel 0024-1171 CASTOR OIL
Sanofi-Aventis US LLC PLAVIX clopidogrel 0024-1171 CELLULOSE, MICROCRYSTALLINE
Sanofi-Aventis US LLC PLAVIX clopidogrel 0024-1171 FERRIC OXIDE RED
Sanofi-Aventis US LLC PLAVIX clopidogrel 0024-1171 HYDROXYPROPYL CELLULOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing clopidogrel

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc clopidogrel 0093-7314 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc clopidogrel 0093-7314 CROSPOVIDONE
Teva Pharmaceuticals USA Inc clopidogrel 0093-7314 FD&C BLUE NO. 2
Teva Pharmaceuticals USA Inc clopidogrel 0093-7314 FERRIC OXIDE RED
Teva Pharmaceuticals USA Inc clopidogrel 0093-7314 FERRIC OXIDE YELLOW
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for clopidogrel

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARNAUBA WAX

Excipient focus: CASTOR OIL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77499

Excipient focus: CI 77891

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COCHINEAL

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CORN OIL

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHICONE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HEMATITE

Excipient focus: HYDROGENATED CASTOR OIL

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHYLCELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 112

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: RICINUS COMMUNIS

Excipient focus: SAND

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: ZINC STEARATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links